Exploring Cartalax: A Closer Look at the Khavinson Peptide Bioregulator

Cartalax is a short chain peptide bioregulator associated with cartilage and connective tissue wellness. Made from a sequence of three amino acids; alanine acid, glutamic acid, and aspartic acid. It has attracted interest among people exploring Khavinson peptide bioregulators and their tissue specific approach.

In the video below, Brenden Henry examines Cartalax and explains why this lesser known peptide is being discussed in relation to cartilage, joints, cellular signaling, and the body’s natural repair processes. He also compares its proposed biological activity with that of better known peptides, including BPC-157.

The video explores research involving IGF-1 and SIRT6, two signaling pathways associated with cellular maintenance, collagen production, tissue response, and healthy aging. Brenden discusses the possibility that Cartalax may influence these pathways within specific tissues rather than simply increasing activity throughout the entire body. These findings remain an area of ongoing research.

The discussion also reviews preliminary human and preclinical research involving cartilage, joint comfort, mobility, inflammatory signaling, and kidney tissue. Importantly, the video emphasizes that joint discomfort and tissue changes can have many different causes. No individual peptide should be viewed as a universal solution, replacement for medical care, or substitute for identifying the underlying cause of a health concern.

GET CARTALAX HERE

These products are not intended to diagnose, treat, cure, or prevent any disease. Always speak with a qualified healthcare professional before starting any supplement routine.